Skip to main content

Table 1 Participant characteristics stratified by the presence of hepatic steatosis

From: A clinically relevant method to screen for hepatic steatosis in overweight adolescents: a cross sectional study

 

Hepatic Steatosis (n = 43)

No Hepatic Steatosis (n = 82)

P-value

Female

24

64

<0.001

Age (yrs)

15 ± 2

15 ± 2

0.53

BMI (kg/m2)

33.8 ± 4.9

31 ± 4.5

0.002

BMI Z score

2.2 ± 0.4

1.9 ± 0.4

<0.001

Waist circumference (cm)

111 ± 12

100 ± 13

<0.001

Body fat percent (%)

38.9 ± 6.1

38 ± 5.9

0.43

Hepatic Triglyceride (%F/W)

13.0 ± 12.5

3.0 ± 1.2

<0.001

HOMA

6.4 ± 8.0

3.6 ± 3.2

0.43

HDL-cholesterol (mmol/L)

1.1 ± 0.3

1.2 ± 0.3

0.23

Triglycerides (mmol/L)

1.6 ± 0.7

1.1 ± 0.5

<0.001

AST (U/L)

26.4 ± 13.7

21.7 ± 8.8

0.008

ALT (U/L)

31.8 ± 22.8

19.0 ± 13.7

<0.001

Systolic BP (mmHg)

116 ± 12

114 ± 11

0.35

Diastolic BP (mmHg)

62 ± 8

65 ± 8

0.08

Metabolic syndrome

40 %

12 %

<0.001

  1. Data are means ± standard deviation unless otherwise stated. BMI Body mass index, HOMA-IR homeostatic model assessment- insulin resistance, HDL High density lipoprotein, AST aspartate aminotransferase, ALT alanine aminotransferase, BP blood pressure